{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:16:49Z","timestamp":1791191809358,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010114","name":"Yrj\u00f6 Jahnsson Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010114","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["fsijournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.forsciint.2013.06.017","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T18:00:59Z","timestamp":1374256859000},"page":"11-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Parenteral buprenorphine\u2013naloxone abuse is a major cause of fatal buprenorphine-related poisoning"],"prefix":"10.1016","volume":"232","author":[{"given":"Margareeta","family":"H\u00e4kkinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pertti","family":"Heikman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Ojanper\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2013.06.017_bib0005","first-page":"183","article-title":"Buprenorphine as postoperative analgesic","volume":"27","author":"Rolly","year":"1976","journal-title":"Acta Anaesthesiol. Belg."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0010","first-page":"187","article-title":"Clinical use of buprenorphine in chronic administration","volume":"27","author":"Adriaensen","year":"1976","journal-title":"Acta Anaesthesiol. Belg."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0015","first-page":"577","article-title":"The metabolism and excretion of buprenorphine in humans","volume":"12","author":"Cone","year":"1984","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archpsyc.1978.01770280111012","article-title":"Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction","volume":"35","author":"Jasinski","year":"1978","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.forsciint.2013.06.017_bib0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0030","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0376-8716(00)00126-5","article-title":"Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine","volume":"61","author":"Harris","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0040","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0376-8716(03)00057-7","article-title":"Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?","volume":"70","author":"Mendelson","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/02791072.2010.10400689","article-title":"Buprenorphine in the treatment of opiate dependence","volume":"42","author":"Wesson","year":"2010","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.forsciint.2013.06.017_bib0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: an international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0379-0738(01)00454-6","article-title":"Deaths involving buprenorphine: a compendium of French cases","volume":"121","author":"Kintz","year":"2001","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00228-011-1122-4","article-title":"Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning","volume":"68","author":"H\u00e4kkinen","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0065","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.forsciint.2012.03.016","article-title":"Toxicological and pathological findings in a series of buprenorphine related deaths. Possible risk factors for fatal outcome","volume":"220","author":"Seld\u00e9n","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0376-8716(93)90036-P","article-title":"The misuse of buprenorphine and a buprenorphine\u2013naloxone combination in Wellington, New Zealand","volume":"33","author":"Robinson","year":"1993","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0075","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s002130050066","article-title":"Effects of buprenorphine versus buprenorphine\/naloxone tablets in non-dependent opioid abusers","volume":"148","author":"Strain","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.forsciint.2013.06.017_bib0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.drugalcdep.2006.09.012","article-title":"Abuse liability of buprenorphine\u2013naloxone tablets in untreated IV drug users","volume":"88","author":"Alho","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/00952990802585406","article-title":"Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine\/naloxone to the Malaysian market","volume":"35","author":"Bruce","year":"2009","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.forsciint.2013.06.017_bib0090","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1360-0443.2009.02843.x","article-title":"Abuse liability of intravenous buprenorphine\/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers","volume":"105","author":"Comer","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2013.06.017_bib0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-010-1898-4","article-title":"Acute effects of intramuscular and sublingual buprenorphine and buprenorphine\/naloxone in non-dependent opioid abusers","volume":"211","author":"Duke","year":"2010","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.forsciint.2013.06.017_bib0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ADM.0b013e3182034e31","article-title":"Illicit use of buprenorphine\/naloxone among injecting and noninjecting opioid users","volume":"5","author":"Bazazi","year":"2011","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.drugalcdep.2011.04.002","article-title":"Post-marketing surveillance of buprenorphine\u2013naloxone in Australia: diversion, injection and adherence with supervised dosing","volume":"118","author":"Larance","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0110","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2011.07.019","article-title":"Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians","volume":"120","author":"Johanson","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0115","article-title":"Urine naloxone concentration at different phases of buprenorphine maintenance treatment","author":"Heikman","year":"2013","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","article-title":"Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved","volume":"105","author":"Degenhardt","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0125","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jat\/32.8.586","article-title":"Urinary detection times and metabolite\/parent compound ratios after a single dose of buprenorphine","volume":"32","author":"Kronstrand","year":"2008","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0130","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1360-0443.1998.93454910.x","article-title":"Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine","volume":"93","author":"Kuhlman","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2013.06.017_bib0135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-200443050-00005","article-title":"Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone","volume":"43","author":"Harris","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0140","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200544070-00001","article-title":"Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence","volume":"44","author":"Elkader","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0145","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/FTD.0b013e3181816214","article-title":"Population pharmacokinetics of intravenous, intramuscular, and intranasal naloxone in human volunteers","volume":"30","author":"Dowling","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0150","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/FTD.0b013e318228bb2a","article-title":"Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women","volume":"33","author":"Concheiro","year":"2011","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0155","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1360-0443.2011.03424.x","article-title":"The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine\/naloxone tablets in opioid abusers","volume":"106","author":"Middleton","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2013.06.017_bib0160","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.drugalcdep.2011.03.024","article-title":"Gender differences in pharmacokinetics of maintenance dosed buprenorphine","volume":"118","author":"Moody","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0165","first-page":"575","article-title":"Disposition of naloxone-7,8,3H in normal and narcotic-dependent men","volume":"187","author":"Fishman","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jat\/33.8.409","article-title":"Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography\u2013electrospray ionization-tandem mass spectrometry","volume":"33","author":"Fang","year":"2009","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0175","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jat\/32.7.516","article-title":"Urinary buprenorphine concentrations in patients treated with Suboxone\u00ae; as determined by liquid chromatography\u2013mass spectrometry and CEDIA immunoassay","volume":"32","author":"Hull","year":"2008","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jat\/bkr020","article-title":"Patterns of free (unconjugated) buprenorphine, norbuprenorphine, and their glucuronides in urine using liquid chromatography\u2013tandem mass spectrometry","volume":"36","author":"McMillin","year":"2012","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0185","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1046\/j.1360-0443.1998.93913859.x","article-title":"Six deaths linked to concomitant use of buprenorphine and benzodiazepines","volume":"93","author":"Reynaud","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2013.06.017_bib0190","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.forsciint.2006.03.037","article-title":"A survey of buprenorphine related deaths in Singapore","volume":"162","author":"Lai","year":"2006","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0195","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.forsciint.2010.05.015","article-title":"Fatal poisoning due to snorting buprenorphine and alcohol consumption","volume":"204","author":"Ferrant","year":"2011","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0200","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0205","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1097\/CCM.0b013e318265680a","article-title":"Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood\u2013brain barrier in mice","volume":"40","author":"Alhaddad","year":"2012","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0210","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.forsciint.2010.10.001","article-title":"Fatal poisoning in drug addicts in the Nordic countries in 2007","volume":"207","author":"Simonsen","year":"2011","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0215","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.forsciint.2012.07.011","article-title":"Comparison of fatal poisonings by prescription opioids","volume":"222","author":"H\u00e4kkinen","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.drugalcdep.2012.07.002","article-title":"Twelve-year trend in treatment seeking for buprenorphine abuse in Finland","volume":"127","author":"Uosukainen","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2013.06.017_bib0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1747-597X-3-16","article-title":"A retrospective evaluation of patients switched from buprenorphine (Subutex) to the buprenorphine\/naloxone combination (Suboxone)","volume":"3","author":"Simojoki","year":"2008","journal-title":"Subst. Abuse Treat. Prev. Policy"}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037907381300340X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037907381300340X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T20:22:47Z","timestamp":1646166167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037907381300340X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":45,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S037907381300340X"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2013.06.017","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parenteral buprenorphine\u2013naloxone abuse is a major cause of fatal buprenorphine-related poisoning","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2013.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}